首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >The role of basic leucine zipper transcription factor E4BP4 in the immune system and immune-mediated diseases
【24h】

The role of basic leucine zipper transcription factor E4BP4 in the immune system and immune-mediated diseases

机译:基础亮氨酸拉链转录因子E4BP4在免疫系统和免疫介导的疾病中的作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Basic leucine zipper transcription factor E4BP4 (also known as NFIL3) has been implicated in the molecular and cellular mechanisms of functions and activities in mammals. The interactions between E4BP4 and major regulators of cellular processes have triggered significant interest in the roles of E4BP4 in the pathogenesis of certain chronic diseases. Indeed, novel discoveries have been emerging to illustrate the involvement of E4BP4 in multiple disorders. It is recognized that E4BP4 is extensively involved in some immune-mediated diseases, but the mechanisms of E4BP4 involvement in these complex diseases remain poorly defined. Here we review the regulatory mechanisms of E4BP4 engaging in not only the biological function but also the development of immune-mediated diseases, paving the way for future therapies. (C) 2017 Published by Elsevier Inc.
机译:基本亮氨酸拉链转录因子E4BP4(也称为NFIL3)涉及哺乳动物中功能和活性的分子和细胞机制。 E4BP4与细胞过程的主要调节剂之间的相互作用引发了E4BP4在某些慢性疾病发病机制中的作用的显着兴趣。 实际上,新的发现已经出现了表明E4BP4在多种障碍中的参与。 据认识到,E4BP4广泛参与一些免疫介导的疾病,但E4BP4参与这些复杂疾病的机制仍然定义不足。 在这里,我们审查了E4BP4的监管机制,不仅是生物学功能,而且还介绍了免疫介导的疾病的发展,为未来的疗法铺平了道路。 (c)2017年由elsevier公司发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号